{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:20:21Z","timestamp":1787772021926,"version":"build-2784847793"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cerebrotendinous xanthomatosis (CTX) is a treatable autosomal recessive disorder with varied clinical manifestations and age of onset and is often diagnosed late. We report three cases of CTX who presented at our center with clinical features of frequent diarrhea, early cataracts, xanthomas, cognitive decline, ataxia, neuropathy, and other manifestations of CTX. Magnetic resonance imaging (MRI) brain in all three patients revealed abnormalities consistent with CTX. Diagnosis was confirmed by next-generation sequencing. Chenodeoxycholic acid (CDCA) is recommended as the drug of choice, as it can halt the disease progression and reverse some of the symptoms. In addition to late diagnosis, nonavailability of CDCA in our part of world adds to the problem of management of such patients; therefore, they are often started on alternative therapies, which are less effective.<\/jats:p>","DOI":"10.4103\/ni.ni_1093_21","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T21:00:09Z","timestamp":1709672409000},"page":"138-141","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Cerebrotendinous Xanthomatosis, a Treatable Disorder Often Missed: Case Series of Three Patients Confirmed by Genetic Testing"],"prefix":"10.4103","volume":"72","author":[{"given":"Arjimand","family":"Yaqoob","sequence":"first","affiliation":[{"name":"Department of Neurology SKIMS, Jammu and Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waseem R.","family":"Dar","sequence":"additional","affiliation":[{"name":"Department of Neurology SKIMS, Jammu and Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Raina","sequence":"additional","affiliation":[{"name":"Department of Neurology SKIMS, Jammu and Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubair","family":"Khuja","sequence":"additional","affiliation":[{"name":"Department of Neurology SKIMS, Jammu and Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Chandra","sequence":"additional","affiliation":[{"name":"Department of Neurology SKIMS, Jammu and Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immia","family":"Bukhari","sequence":"additional","affiliation":[{"name":"Department of Neurology SKIMS, Jammu and Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilal","family":"Ganie","sequence":"additional","affiliation":[{"name":"Department of Neurology SKIMS, Jammu and Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maqbool","family":"Wani","sequence":"additional","affiliation":[{"name":"Department of Neurology SKIMS, Jammu and Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravouf","family":"Asimi","sequence":"additional","affiliation":[{"name":"Department of Neurology SKIMS, Jammu and Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,2,29]]},"reference":[{"key":"R1-20240907","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10072-006-0618-7","article-title":"Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene","volume":"27","author":"Gallus","year":"2006","journal-title":"Neurol Sci"},{"key":"R2-20240907","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1001\/archneur.62.9.1459","article-title":"Cerebrotendinous xanthomatosis:Possible higher prevalence than previously recognized","volume":"62","author":"Lorincz","year":"2005","journal-title":"Arch Neurol"},{"key":"R3-20240907","first-page":"433","article-title":"The framework of the xanthomatoses and their different types. 2. Secondary xanthomatoses","volume":"17","author":"Van","year":"1962","journal-title":"Rev Med Liege"},{"key":"R4-20240907","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0006-2944(75)90020-4","article-title":"Chenodeoxycholic acid inhibits increased cholesterol and cholestanol synthesis in patients with cerebrotendinous xanthomatosis","volume":"14","author":"Salen","year":"1975","journal-title":"Biochem Med"},{"key":"R5-20240907","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJM198412273112601","article-title":"Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid","volume":"311","author":"Berginer","year":"1984","journal-title":"N Engl J Med"},{"key":"R6-20240907","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/S0022-2275(20)32474-3","article-title":"Transcriptional activation of the cholesterol 7alpha-hydroxylase gene (CYP7A) by nuclear hormone receptors","volume":"39","author":"Crestani","year":"1998","journal-title":"J Lipid Res"},{"key":"R8-20240907","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0022-2275(20)38325-5","article-title":"Chenodeoxycholic acid normalizes elevated lipoprotein secretion and catabolism in cerebrotendinous xanthomatosis","volume":"30","author":"Tint","year":"1989","journal-title":"J Lipid Res"},{"key":"R9-20240907","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1023\/A:1021211520034","article-title":"Mutations in the sterol 27-hydroxylase gene (CYP27A) cause hepatitis of infancy as well as cerebrotendinous xanthomatosis","volume":"25","author":"Clayton","year":"2002","journal-title":"J Inherit Metab Dis"},{"key":"R10-20240907","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0002-9394(14)72206-8","article-title":"Ocular and systemic manifestations of cerebrotendinous xanthomatosis","volume":"120","author":"Cruysberg","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"R11-20240907","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jacl.2018.06.008","article-title":"Diagnosis, treatment, and clinical outcomes in 43 cases with cerebrotendinous xanthomatosis","volume":"12","author":"Duell","year":"2018","journal-title":"J Clin Lipidol"},{"key":"R12-20240907","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0026-0495(93)90174-M","article-title":"Osteoporosis and increased bone fractures in cerebrotendinous xanthomatosis","volume":"42","author":"Berginer","year":"1993","journal-title":"Metabolism"},{"key":"R13-20240907","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1528-1157.1991.tb04705.x","article-title":"Epileptic seizure as a presenting symptom of cerebrotendinous xanthomatosis.","volume":"32","author":"Arlazoroff","year":"1991","journal-title":"Epilepsia"},{"key":"R14-20240907","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1471-2377-11-63","article-title":"Neuromuscular abnormality and autonomic dysfunction in patients with cerebrotendinous xanthomatosis","volume":"11","author":"Chen","year":"2011","journal-title":"BMC Neurol"},{"key":"R15-20240907","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1148\/radiology.217.3.r00dc03869","article-title":"Cerebrotendinous xanthomatosis:The spectrum of imaging findings and the correlation with neuropathologic findings","volume":"217","author":"Barkhof","year":"2000","journal-title":"Radiology"},{"key":"R16-20240907","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10545-017-0093-8","article-title":"Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX)","volume":"40","author":"Salen","year":"2017","journal-title":"J Inherit Metab Dis"},{"key":"R17-20240907","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0009-8981(85)90182-2","article-title":"Bile acid therapies applied to patients suffering from cerebrotendinous xanthomatosis","volume":"152","author":"Koopman","year":"1985","journal-title":"Clin Chim Acta"},{"key":"R18-20240907","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1177\/08830738030180091001","article-title":"Cerebrotendinous xanthomatosis:Clinical manifestations, diagnostic criteria, pathogenesis, and therapy","volume":"18","author":"Federico","year":"2003","journal-title":"J Child Neurol"}],"container-title":["Neurology India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ni.ni_1093_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:25:43Z","timestamp":1787768743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ni.ni_1093_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ni.ni_1093_21","relation":{},"ISSN":["0028-3886","1998-4022"],"issn-type":[{"value":"0028-3886","type":"print"},{"value":"1998-4022","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"2021-10-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}